Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.

Dicker AJ, Crichton ML, Cassidy AJ, Brady G, Hapca A, Tavendale R, Einarsson GG, Furrie E, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

Thorax. 2018 Jun;73(6):510-518. doi: 10.1136/thoraxjnl-2016-209931. Epub 2017 Nov 3.

2.

European Respiratory Society guidelines for the management of adult bronchiectasis.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep.

PMID:
28889110
3.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

4.

Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.

Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, Dicker A, Wrobel K, Elborn JS, Walker B, Martin SL, Marshall SE, Huang JT, Fardon TC.

Am J Respir Crit Care Med. 2017 May 15;195(10):1384-1393. doi: 10.1164/rccm.201605-1027OC.

5.

Third Places for Health Promotion with Older Adults: Using the Consolidated Framework for Implementation Research to Enhance Program Implementation and Evaluation.

Northridge ME, Kum SS, Chakraborty B, Greenblatt AP, Marshall SE, Wang H, Kunzel C, Metcalf SS.

J Urban Health. 2016 Oct;93(5):851-870.

6.

Dr. Marshall Responds.

Marshall SE, Northridge ME, Lamster IB; Authorship Team and Eldersmile Program.

J Calif Dent Assoc. 2015 Dec;43(12):701-2. No abstract available.

7.

The Impact of Medicaid Expansion on Oral Health Equity for Older Adults: A Systems Perspective.

Northridge ME, Metcalf SS, Birenz SS, Kunzel C, Wang H, Schrimshaw EW, Marshall SE.

J Calif Dent Assoc. 2015 Jul;43(7):369-77.

8.

The ElderSmile TimeMap: Benefits of Connecting Statistics With Time and Place.

Kum SS, Wang H, Wang P, Jin Z, De La Cruz L, Northridge ME, Kunzel C, Marshall SE, Metcalf SS.

Am J Public Health. 2015 Sep;105(9):1748-50. doi: 10.2105/AJPH.2015.302730. Epub 2015 Jul 16.

9.

A community-based oral public health approach to promote health equity.

Northridge ME, Yu C, Chakraborty B, Port Greenblatt A, Mark J, Golembeski C, Cheng B, Kunzel C, Metcalf SS, Marshall SE, Lamster IB.

Am J Public Health. 2015 Jul;105 Suppl 3:S459-65. doi: 10.2105/AJPH.2015.302562. Epub 2015 Apr 23.

10.

Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

Wadelius M, Marshall SE, Islander G, Nordang L, Karawajczyk M, Yue QY, Terreehorst I, Baranova EV, Hugosson S, Sköldefors K, Pirmohamed M, Maitland-van der Zee AH, Alfirevic A, Hallberg P, Palmer CN.

Clin Pharmacol Ther. 2014 Oct;96(4):477-81. doi: 10.1038/clpt.2014.138. Epub 2014 Jun 24.

11.

Patterns of chronic conditions in older adults: exploratory spatial findings from the ElderSmile program.

Widener MJ, Northridge ME, Chakraborty B, Marshall SE, Lamster I, Kum S, Metcalf SS.

Am J Prev Med. 2014 Jun;46(6):643-8. doi: 10.1016/j.amepre.2014.01.013.

12.

Modeling social dimensions of oral health among older adults in urban environments.

Metcalf SS, Northridge ME, Widener MJ, Chakraborty B, Marshall SE, Lamster IB.

Health Educ Behav. 2013 Oct;40(1 Suppl):63S-73S. doi: 10.1177/1090198113493781.

13.

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012.

Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V, Panahloo Z, Workman S, Slatter M, Gennery AR, Davies EG, Allwood Z, Arkwright PD, Helbert M, Longhurst HJ, Grigoriadou S, Devlin LA, Huissoon A, Krishna MT, Hackett S, Kumararatne DS, Condliffe AM, Baxendale H, Henderson K, Bethune C, Symons C, Wood P, Ford K, Patel S, Jain R, Jolles S, El-Shanawany T, Alachkar H, Herwadkar A, Sargur R, Shrimpton A, Hayman G, Abuzakouk M, Spickett G, Darroch CJ, Paulus S, Marshall SE, McDermott EM, Heath PT, Herriot R, Noorani S, Turner M, Khan S, Grimbacher B.

Clin Exp Immunol. 2014 Jan;175(1):68-78. doi: 10.1111/cei.12172.

14.

Effect of lipid and fatty acid composition of phospholipid vesicles on long-term stability and their response to Staphylococcus aureus and Pseudomonas aeruginosa supernatants.

Marshall SE, Hong SH, Thet NT, Jenkins AT.

Langmuir. 2013 Jun 11;29(23):6989-95. doi: 10.1021/la401679u. Epub 2013 May 28.

PMID:
23668367
15.

Integrating oral and general health screening at senior centers for minority elders.

Marshall SE, Cheng B, Northridge ME, Kunzel C, Huang C, Lamster IB.

Am J Public Health. 2013 Jun;103(6):1022-5. doi: 10.2105/AJPH.2013.301259. Epub 2013 Apr 18.

16.

Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK.

Walker DG, Williams HR, Kane SP, Mawdsley JE, Arnold J, McNeil I, Thomas HJ, Teare JP, Hart AL, Pitcher MC, Walters JR, Marshall SE, Orchard TR.

Am J Gastroenterol. 2011 Jul;106(7):1281-9. doi: 10.1038/ajg.2011.85. Epub 2011 May 17.

PMID:
21577243
17.
18.

Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease.

Williams HR, Cox IJ, Walker DG, Cobbold JF, Taylor-Robinson SD, Marshall SE, Orchard TR.

BMC Gastroenterol. 2010 Sep 17;10:108. doi: 10.1186/1471-230X-10-108.

19.

Characterization of inflammatory bowel disease with urinary metabolic profiling.

Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR.

Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28. Erratum in: Am J Gastroenterol. 2009 Jul;104(7):1894.

PMID:
19491857
20.
21.

Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.

Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM, du Bois RM, Welsh KI.

Tissue Antigens. 2007 Sep;70(3):219-27.

PMID:
17661910
22.

Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis.

Spagnolo P, Sato H, Marshall SE, Antoniou KM, Ahmad T, Wells AU, Ahad MA, Lightman S, du Bois RM, Welsh KI.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3019-25.

PMID:
17591867
23.

Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy.

Kropf P, Baud D, Marshall SE, Munder M, Mosley A, Fuentes JM, Bangham CR, Taylor GP, Herath S, Choi BS, Soler G, Teoh T, Modolell M, Müller I.

Eur J Immunol. 2007 Apr;37(4):935-45.

24.

Genetics of inflammatory bowel disease: the role of the HLA complex.

Ahmad T, Marshall SE, Jewell D.

World J Gastroenterol. 2006 Jun 21;12(23):3628-35. Review.

25.

A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis.

Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI.

Int J Immunogenet. 2006 Jun;33(3):155-61.

PMID:
16712644
26.

CARD15 polymorphisms in Behçet's disease.

Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE.

Scand J Rheumatol. 2005 May-Jun;34(3):233-7.

PMID:
16134731
27.

Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression.

Loucaidou M, Stitchbury J, Lee J, Borrows R, Marshall SE, McLean AG, Cairns T, Griffith M, Hakim N, Palmer A, Papalois V, Welsh K, Taube D.

Transplant Proc. 2005 May;37(4):1760-1.

PMID:
15919456
28.

A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load.

Asquith B, Mosley AJ, Barfield A, Marshall SE, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CR.

J Gen Virol. 2005 May;86(Pt 5):1515-23.

PMID:
15831965
29.

The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.

Fabre MA, Jones DC, Bunce M, Morris PJ, Friend PJ, Welsh KI, Marshall SE.

Transpl Int. 2004 Oct;17(9):531-9. Epub 2004 Sep 2.

30.

Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, Bangham CR, Osame M.

J Infect Dis. 2004 Oct 1;190(7):1279-85. Epub 2004 Aug 31.

PMID:
15346339
31.

Behçet's disease.

Marshall SE.

Best Pract Res Clin Rheumatol. 2004 Jun;18(3):291-311. Review.

PMID:
15158742
32.

Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis.

Tikly M, Marshall SE, Haldar NA, Gulumian M, Wordsworth P, Welsh KI.

Free Radic Biol Med. 2004 Jun 1;36(11):1403-7.

PMID:
15135176
33.

Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease.

Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR, Fortune F, Jewell DP, Marshall SE.

Eur J Immunogenet. 2004 Feb;31(1):11-4. Erratum in: Eur J Immunogenet. 2005 Jun;32(3):219. Verity, D [added].

PMID:
15009175
34.

Genetic variation in COL17A1 and the development of bullous pemphigoid.

Winsey S, Lonie L, Allen J, Bunce M, Marshall SE, Wojnarowska F.

Exp Dermatol. 2004 Mar;13(3):140-7.

PMID:
14987253
35.

Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles.

Jones DC, Bunce M, Fuggle SV, Young NT, Marshall SE.

Eur J Immunogenet. 2003 Dec;30(6):415-9.

PMID:
14675395
36.

The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis.

Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP.

Tissue Antigens. 2003 Dec;62(6):527-35.

PMID:
14617036
37.

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation.

Marsh HP, Haldar NA, Bunce M, Marshall SE, le Monier K, Winsey SL, Christodoulos K, Cranston D, Welsh KI, Harris AL.

Br J Cancer. 2003 Sep 15;89(6):1096-101.

38.

Dental caries experience in northern Manhattan adolescents.

Mitchell DA, Ahluwalia KP, Albert DA, Zabos GP, Findley SE, Trinh-Shevrin CB, Marshall SE, Lamster IB, Formicola AJ.

J Public Health Dent. 2003 Summer;63(3):189-94.

PMID:
12962473
39.

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.

Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP.

Gut. 2003 Aug;52(8):1133-9.

40.

The impact of endothelial nitric oxide synthase polymorphisms on long-term renal allograft outcome.

Shenker NS, Haldar NA, Reilly JJ, Bunce M, Welsh KI, Marshall SE.

Transpl Int. 2003 Jun;16(6):391-5. Epub 2003 Mar 26.

PMID:
12819869
41.

Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?

Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP.

Arthritis Rheum. 2003 Mar;48(3):807-13.

42.

Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC.

Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling KL, Barnardo M, Goldthorpe S, Walton R, Bunce M, Jewell DP, Welsh KI.

Hum Mol Genet. 2003 Mar 15;12(6):647-56.

PMID:
12620970
43.

Comprehensive hereditary hemochromatosis genotyping.

Jones DC, Young NT, Pigott C, Fuggle SV, Barnardo MC, Marshall SE, Bunce M.

Tissue Antigens. 2002 Dec;60(6):481-8.

PMID:
12542741
44.

HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.

Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, Bull P, Bunce M, Welsh K, Marshall SE, Borysiewicz L.

J Virol. 2003 Feb;77(3):1927-39.

45.

High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.

Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A, Neville M, van Heel D, Barnardo M, Welsh KI, Jewell DP, Bunce M.

Tissue Antigens. 2002 Aug;60(2):164-79.

PMID:
12392511
46.

Genetic determinants of delayed graft function after kidney transplantation.

St Peter SD, Imber CJ, Jones DC, Fuggle SV, Watson CJ, Friend PJ, Marshall SE.

Transplantation. 2002 Sep 27;74(6):809-13.

PMID:
12364860
47.

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham CR.

J Infect Dis. 2002 Oct 1;186(7):932-9. Epub 2002 Sep 13.

PMID:
12232833
48.

The molecular classification of the clinical manifestations of Crohn's disease.

Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, de Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP.

Gastroenterology. 2002 Apr;122(4):854-66. Erratum in: Gastroenterology. 2003 Jul;125(1):281.

PMID:
11910336
49.

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine.

Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, Bunce M, Welsh KI, Marshall SE, Oxford J.

J Infect Dis. 2002 Jan 1;185(1):114-7. Epub 2001 Dec 14.

PMID:
11756990
50.

Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.

Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI.

Clin Endocrinol (Oxf). 2001 Oct;55(4):491-9.

PMID:
11678832

Supplemental Content

Loading ...
Support Center